These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7835128

  • 1. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
    Ge XL, Lou SZ, Shen HM.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
    [Abstract] [Full Text] [Related]

  • 2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 3. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V, Nagamani M.
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [Abstract] [Full Text] [Related]

  • 4. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF, Ren FR, Guo SP.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [Abstract] [Full Text] [Related]

  • 5. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S.
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [Abstract] [Full Text] [Related]

  • 6. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 7. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
    Pérez-Bravo F, Echiburú B, Maliqueo M, Santos JL, Sir-Petermann T.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
    [Abstract] [Full Text] [Related]

  • 8. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C, Renteria JL, Moran S, Herrera J, Gonzalez S, Bermudez JA.
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [Abstract] [Full Text] [Related]

  • 9. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 11. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H, Takahashi K, Miyazaki K.
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
    Rocha MP, Maranhão RC, Seydell TM, Barcellos CR, Baracat EC, Hayashida SA, Bydlowski SP, Marcondes JA.
    Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
    Guido M, Romualdi D, De Marinis L, Porcelli T, Giuliani M, Costantini B, Lanzone A.
    Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D, Barletta C, Cioli I, Scavo D.
    Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
    [Abstract] [Full Text] [Related]

  • 19. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M, Orbetsova V, Kamenov Z, Kolarov G, Andreeva M, Genchev G, Zakharieva S, Borisov I.
    Akush Ginekol (Sofiia); 2003 Mar; 42(4):10-5. PubMed ID: 14577361
    [Abstract] [Full Text] [Related]

  • 20. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D, De Marinis L, Campagna G, Proto C, Lanzone A, Guido M.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.